Summary
Before the onset of histologically detectable alterations of diabetic arteries, a considerable decrease of vasodilation ability develops. The role of an altered prostaglandin biosynthesis in this phenomenon was investigated in connection to the altered vascular adrenergic mechanisms. The effect of phenylephrine on prostacyclin production of isolated coronary arterial rings (100 μmol/l) as well as on conductivity of the coronary arterial bed (7.5-15-30-60 pmol·kg−1·min−1) were compared in 12 metabolically healthy and 12 alloxan-diabetic (560 μmol/kg) dogs. Furthermore, the effect of phentolamine (5 μmol/l) on the prostacyclin and thromboxane productions of the isolated vessels (coronary, femoral and basilar arteries) was investigated by radioimmunoassay. Although the basal prostacyclin amounts synthesized by healthy and diabetic coronary vessels were not different (5.1±1.6 and 4.9±1.4pg/mg vessel/30 min), similarly to femoral and basilar arteries, the diabetic arterial rings produced significantly (p<0.05) more thromboxane than the control rings. The α-adrenergic blockade by phentolamine did not influence the prostacyclin production in the healthy arteries, but considerably (p<0.05) increased it in the diabetic coronary arteries. Phentolamine normalised the thromboxane synthesis in the diabetic group (p<0.01) and enhanced (p<0.05) it in the metabolically healthy group. Phenylephrine was ineffective (98±6%) on the prostacyclin production in vitro versus the stimulated (150±22%) prostacyclin synthesis detected in the metabolically healthy group; and in vivo induced a more significant (p<0.05) decrease in the coronary conductivity in diabetic than in control groups. These results refer to the supposition that altered adrenergic mechanisms are involved in the imbalamce of the vasoactive prostaglandins contributing to the high incidence of ischaemic heart disease in diabetes mellitus.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Busse R, Bassenge E (1984) Modulation des Koronargefäβtonus: Molekuläre und zelluläre Mechanismen. Z Kardiol 73: 477–491
Moncada S (1982) Biological importance of prostacyclin. Br J Pharmacol 76: 3–31
Brody MJ, Dixon RL (1964) Vascular reactivity in experimental diabetes mellitus. Circ Res 14: 494–501
Bohlen HG, Hankins KD (1982) Early arteriolar and capillary changes in streptozotocin-induced diabetic rats and intraperitoneal hyperglycaemic rats. Diabetologia 22: 344–348
Mueller SM, Mueller RM, Ertel PJ (1982) Sympathetic and vascular dysfunction in early experimental juvenile diabetes mellitus. Am J Physiol 243: H139–144
Fortes ZB, Garcia-Leme J, Scivoletto R (1983) Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell. Br J Pharmacol 83: 635–643
Sullivan S, Sparks HV (1979) Diminished contractile response of aortas from diabetic rabbits. Am J Physiol 236: H301–306
Christlieb AR (1974) Renin, angiotensin and norepinephrine in alloxan-diabetes. Diabetes 23: 962–970
Jackson CV, Carrier GO (1981) Supersensitivity of isolated mesenteric arteries to noradrenaline in the long-term experimental diabetic rat. J Auton Pharmacol 1: 399–405
Zitnay M (1986) Augmented adrenergic responses of diabetic carotid arteries are dependent on the endothelium. Circulation 74: 413 (Abstract)
Owen MP, Carrier GO (1980) Calcium dependence of norepinephrine-induced vascular contraction in experimental diabetes. J Pharmacol Exp Ther 212: 253–258
MacLeod KM, McNeill JH (1985) The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can J Physol Pharmacol 63: 52–577
Cseuz R, Wenger TL, Kunos G, Szentiványi M (1973) Changes of adrenergic reaction pattern in experimental diabetes. Endocrinology 93: 752–755
Sterin-Borda L, Borda ES, Gimeno M, Lazzari MA, DelCastillo E, Gimeno AL (1982) Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs. Diabetologia 22: 56–59
Roth DM, Reibel DK, Lefer AM (1983) Vascular responsiveness and eicosanoids production in diabetic rats. Diabetologia 24: 372–376
Palik I, Koltai MZ, Hadházy P, Malomvölgyi B, Wagner M, Pogátsa G (1982) Effects of prostaglandins E2, I2 and F2α on the tone of isolated coronary arteries from alloxan-diabetic dogs. Prostaglandins Leukotrunes Med 8: 607–617
Harrison HE, Reece AH, Johnson M (1978) Decreased vascular prostacyclin in experimental diabetes. Life Sci 23: 354–356
Rogers SP, Larking S (1981) Production of 6-oxo PGF1α by rat aorta, influence of diabetes, insulin treatment and caloric deprivation. Diabetes 30: 19–33
Rösen P, Rösen R, Hohl C, Reinauer H, Klaus W (1984) Reduced transcoronary exchange and prostaglandin synthesis in the diabetic rat heart. Am J Physiol 247: H372–376
Wey HE, Subbiah MTR (1984) Altered aortic prostaglandin synthesis in a mild form of diabetes and the influence of dietary cholesterol. J Lab Clin Med 104: 312–320
Subbiah MTR, Deitemeyer D (1980) Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats. Biochem Med 23: 231–235
Ganda MP (1980) Pathogenesis of macrovascular disease in the human diabetes. Diabetes 29: 931–942
Wennmalm A, Brundin T (1978) Prostaglandin mediated inhibition of noradrenaline release IV. Prostaglandin synthesis is stimulated by myocardial adrenoceptors differing from the α and β type. Acta Physiol Scand 102: 374–381
Conard V, Franckson JRM, Bastenie PA, Kestens J, Kovács L (1953) Etude critique du triangle d, hyperglycemie intraveineux chez l, homme et determination d, un coefficient d, assimilation glucidique. Arch Int Pharmacodyn Ther 93: 277–292
Trinder P (1969) Determination of blood glucose using an oxydase-peroxydase system with a non-carcinogenic chromogen. J Clin Pathol 22: 158–161
Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Pathol 13: 156–159
Neuweiler W (1933) Quantitative Bestimmung der Acetonkörper im Blut mittels des Stufenphotometers. Klin Wochenschr 12: 869–890
Boeynaems JM, Galand N, Ketelbant P (1985) Prostacyclin production by the deendothelialized rabbit aorta. Klin Invest 76: 7–14
Jeremy JY, Mikhailidis DP, Dandona P (1985) Adrenergic modulation of vascular prostacyclin (PGI2) secretion. eur J Pharmacol 114: 33–40
Valentovic MA, Lubawy WC (1983) Impact of insulin or tolbutamide treatment on 14C arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas and platelets of streptozotocin induced diabetic rats. Diabetes 32: 846–851
Colwell JA, Wincour PD, Lopes-Virella M, Halushka PV (1983) New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 75: 67–81
Johnson M, Harrison HE, Raferty AT, Elder JB (1979) Vascular prostacyclin may be reduced in diabetes in man. Lancet I: 325–326
Carreras LO, Chamome DAF, Klerck P, Vermylen J (1980) Decreased vascular PGI2 release in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound BAY 6575. Thromb Res 19: 663–670
McNamara DB, Donath GR, Kadowitz PJ, Hyman AL, Rush DS, Kerstein MD (1986) Prostacyclin synthetase activity in human diabetic and non-diabetic vascular tissue. J Vasc Surg 4: 63–67
Myers TO, Messina EJ, Rodrigues AM, Gerritsen ME (1985) Altered aortic and cremaster muscle prostaglandin synthesis in diabetic rats. Am J Physiol 249: E374–379
Gerrard JM, Stuart MJ, Rao GHR, Steffes MW, Mauer SM, Brown DM, White JG (1980) Alterations in the balance of prostacyclin and thromboxane synthesis in diabetes. J Lab Clin Med 95: 950–955
Belo SE, Talesnik J (1982) Coronary vasoconstrictor and vasodilator actions of arachidonic acid in the isolated perfused heart of the rat. Br J Pharmacol 75: 269–286
Sterin-Borda L, Franchi AM, Borda ES, DelCastillo E, Gimeno MF, Gimeno AL (1984) Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is concident with the vascular tone enhancement evoked by Na-arachidonate and prostacyclin. Eur J Pharmacol 103: 211–221
Horrobin DF (1980) A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2. Med Hypotheses 15: 953–961
Karpen CW, Pritchard KA, Merola AJ, Panganamala RV (1982) Alterations of the prostacyclin-thromboxane ratio in streptozotcin induced diabetic rats. Prostaglandins Leukotrienes Med 8: 93–103
Fujii K, Soma M, Huang YS, Manku MS, Horrobin DF (1986) Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: the effects of glucose and insulin. Prostaglandins Leukotrienes Med 24: 151–161
Gimeno AL, Sterin-Borda L, Borda ES, DelCastillo EJ, Gimeno MF (1983) Arachidonate evokes constriction of coronary and mesenteric arteries isolated from diabetic dogs. In: Samuelsson B, Paoletti R, Ramwell P (eds) Advances in prostaglandin thromboxane and leukotriene research, Vol 12. Raven Press, New York, pp 235–240
Jeremy JY, Thompson CS, Mikhailidis DP, Dandona P (1986) Duration and not severity of diabetes mellitus determines effects on prostacyclin synthesis in the rat aorta, penis and bladder. Prog Lipid Res 25: 507–509
Needleman P, Minkes M, Raz A (1976) Thromboxanes: selective biosynthesis and distinct biological properties. Science 193: 163–165
Stewart D, Pountney E, Fitchett D (1984) Norepinephrine stimulated vascular prostacyclin synthesis, Receptor dependent calcium channels control prostaglandin synthesis. Can J Physiol Pharmacol 62: 1341–1347
Peredo H, Agostini M, Gimeno MF, Sterin-Borda DE (1984) Hypersensitivity to norepinephrine in vasa deferentia from diabetic rats. Possible participation of metabolic products of arachidonic acid. Prostaglandins Leukotrienes Med 15: 229–239
Rösen P, Schrör K (1980) Increased prostacyclin release from perfused hearts of acutely diabetic rats. Diabetologia 18: 391–394
Koltai MZ, Jermendy GY, Kiss V, Wagner M, Pogátsa G (1984) The effects of sympathetic stimulation and adenosine concoronary circulation and heart function in diabetes mellitus. Acta Physiol Hung 63: 119–125
Scarborough NL, Carrier GO (1983) Increased α2 adrenoceptor mediated vascular contraction in diabetic rats. J Auton Pharmacol 3: 177–183
Amenta D, Cavallotti C, Collier WL, deRossi M, Ricci A, Amenta F (1987) Noradrenergic innervation of the superior mesenteric artery in streptozotocin-diabetic rats. Acta Histochem Cytochem 20: 177–184
Felten SY, Petersen RG, Shea PA, Besch HR, Felten DL (1982) Effect of streptozotocin diabetes on the noradrenergic innervation of the heart: a longitudinal histofluorescence and neurochemical study. Brain Res Bull 8: 593–607
Trendelenburg U (1966) Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 18: 629–640
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koltai, M.Z., Rösen, P., Hadházy, P. et al. Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries. Diabetologia 31, 681–686 (1988). https://doi.org/10.1007/BF00278752
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00278752